Erectile dysfunction in the cardiac patient: how common and should we treat?
about
Clinical significance of erectile dysfunction developing after acute coronary event: exception to the rule or confirmation of the artery size hypothesis?Vardenafil for the treatment of erectile dysfunction: an overview of the clinical evidenceGeneral practitioner views about discussing sexual issues with patients with coronary heart disease: a national survey in IrelandDimethylarginine dimethylaminohydrolase in rat penile tissue: reduced enzyme activity is responsible for erectile dysfunction in a rat model of atherosclerosis.Should patients with erectile dysfunction be evaluated for cardiovascular disease?Management of erectile dysfunction in hypertension: Tips and tricks.Evaluations of erectile dysfunction before and after on-pump coronary artery bypass graft surgery.Antihypertensive drugs and erectile dysfunction as seen in spontaneous reports, with focus on angiotensin II type 1 receptor blockers.Erectile dysfunction as a marker for cardiovascular disease diagnosis and intervention: a cost analysis.Sexual Dysfunction before and after Cardiac Rehabilitation.The effect of tadalafil on the time to exercise-induced myocardial ischaemia in subjects with coronary artery disease.Erectile dysfunction in patients with coronary artery disease.The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience.Vasculogenic erectile dysfunction: beyond the haemodynamic changes.Can Erectile Dysfunction in Young Patients Serve as a Surrogate Marker for Coronary Artery Disease?Why do patients with heart failure suffer from erectile dysfunction? A critical review and suggestions on how to approach this problem.A multidisciplinary approach to assess erectile dysfunction in high-risk cardiovascular patients.Erectile dysfunction and coronary atherothrombosis in diabetic patients: pathophysiology, clinical features and treatment.Potency and selectivity of vardenafil: a phosphodiesterase Type 5 inhibitor.Reactive oxygen species and erectile dysfunction: possible role of NADPH oxidase.Erectile dysfunction as a predictor of cardiovascular disease.Prevention of cardiovascular disease by the early identification of erectile dysfunction.The CopenHeartSF trial--comprehensive sexual rehabilitation programme for male patients with implantable cardioverter defibrillator or ischaemic heart disease and impaired sexual function: protocol of a randomised clinical trial.Association between erectile dysfunction and coronary artery disease and its severity.How to save a life during a clinic visit for erectile dysfunction by modifying cardiovascular risk factors.Sexual health of male cardiac patients - present status and expectations of patients with coronary heart disease.Emerging role for TNF-α in erectile dysfunction.Erectile dysfunction as a cardiovascular risk factor in patients with diabetes.Pathophysiological role of the renin-angiotensin system on erectile dysfunction.Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management.History of erectile dysfunction as a predictor of poor physical performance after an acute myocardial infarction.Aldosterone induces inflammatory cytokines in penile corpus cavernosum by activating the NF-κB pathway.The relation between erectile dysfunction and extent of coronary artery disease in the patients with stable coronary artery disease.Coronary flow velocity reserve reduction is comparable in patients with erectile dysfunction and in patients with impaired fasting glucose or well-regulated diabetes mellitus.Prevalence of Erectile Dysfunction in Atrial Fibrillation Patients: A Cross-Sectional, Epidemiological Study.Evaluation of vascular smooth muscle and corpus cavernosum on hypercholesterolemia. Is resveratrol promising on erectile dysfunction?Sexual concerns and practices after ICD implantation: findings of the COPE-ICD rehabilitation trial.ED and quality of life in CABG patients: an intervention study using PRECEDE-PROCEED educational program.The prevalence and clinical relevance of sexual dysfunction in women and men with chronic heart failure.Initial validation of a novel rat model of vasculogenic erectile dysfunction with generalized atherosclerosis.
P2860
Q26829068-A25E717C-2487-4709-9C4B-89E8041DDDFCQ33571010-A8D9244C-C045-4D87-922A-5ECF04EB4C03Q33586791-77550E30-350A-4367-A8F1-193ECFD08B72Q33711152-92BBF4DD-77F9-48CB-BBFC-DF0490C389B1Q34084516-642C9C92-B375-4B68-A430-831E27F40113Q34251875-C48DE358-786F-45A9-B214-AF2990E738A2Q34586101-A4A44787-8654-4AA2-A713-CD223F65F04AQ35026492-A618CF9A-8E34-4ACA-9A62-B40A6A8C80F8Q35328376-1A807FD6-1887-439B-A0DE-6069E7B76ED1Q35380548-DEE663F3-B307-47DC-8079-348C6A30FD3CQ35827206-89D73DCC-5286-4B57-99F8-7F56DC75C2BBQ36053660-04024126-2009-49FE-80B3-993851B4760AQ36116915-0253C75E-CE52-4D44-BAE6-FE2F73DED9CEQ36335059-FCFDDFD3-67FC-4379-B157-1FBC30063A9BQ36343594-97D8D6AB-7BF0-4E69-B303-CB874D72497EQ36359845-5A77ABBD-39CE-4C94-B93B-53F7403E9DBFQ36359849-7F10CCF0-F51F-4A38-A4B2-456342A7BC6FQ36410421-DF884CC0-0398-4F05-B89A-846B79BA52E6Q36572595-6D68C78B-B509-4196-AE48-F94DA98E171BQ36629849-67208B47-4EB4-4035-B3B9-B2F2F74D63FDQ37164057-79E6D921-E741-4A2D-9DB9-DFCF1CDAFEEDQ37323294-AEAE3277-DA0B-46F9-A6F7-6B266548C11BQ37352860-5D5160EB-B1D8-4636-A743-EBB6D73114C5Q37388112-83B4C192-18EE-492F-AE55-D0210E890E73Q37582767-FE336737-B7F4-4943-AAA5-CE60CE2BB6F2Q37675579-424E99FE-D2D5-47E3-BF7B-218596847AC6Q37719686-A7E56E2F-FCA2-4D5F-A9CA-EEC59001D397Q38040688-7B14AC7F-66F5-47B2-BBA4-099106A047E1Q38126111-1528E7FB-B47F-40C2-8A46-C2B6ABA296C9Q38179262-86418A9B-AE46-4E93-8981-2C3A78C92295Q38773001-FC23BCB6-D3C1-4685-A690-FFEC75FDBCFCQ38850832-A78C8500-ED95-49BF-871A-3BCAB84E23F8Q38907130-1AA00FCE-C393-4948-9F2B-5BAF523EDEA3Q40221529-55DD4E12-1EE1-4211-B39B-F1DF2EC01B03Q40493899-61CB632B-7715-46ED-8703-871651C28E4BQ42993820-0FB040E5-7691-4EC8-838B-2D626E479623Q43650463-8A827FD0-5AC1-4C74-AE72-8C3962E0116FQ44322934-DC422485-36E3-4C2F-95AF-93A713A3B710Q45987400-E979AE3D-47D9-482E-8ABD-856B15499391Q46486413-07C2F4C9-06C3-4DF4-B879-145EC566AEE6
P2860
Erectile dysfunction in the cardiac patient: how common and should we treat?
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Erectile dysfunction in the cardiac patient: how common and should we treat?
@ast
Erectile dysfunction in the cardiac patient: how common and should we treat?
@en
type
label
Erectile dysfunction in the cardiac patient: how common and should we treat?
@ast
Erectile dysfunction in the cardiac patient: how common and should we treat?
@en
prefLabel
Erectile dysfunction in the cardiac patient: how common and should we treat?
@ast
Erectile dysfunction in the cardiac patient: how common and should we treat?
@en
P2093
P1476
Erectile dysfunction in the cardiac patient: how common and should we treat?
@en
P2093
Charles Pollick
Guy Mayeda
Harin Padma-Nathan
Harry Peled
Ranji Choudhary
Ray Matthews
Raymond Rosen
Robert A Kloner
Stephanie H Mullin
Steve Burstein
P304
S46-50; discussion S50
P356
10.1097/01.JU.0000075055.34506.59
P407
P433
P577
2003-08-01T00:00:00Z